These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 12132472)

  • 1. Concerns over kava have the FDA's attention.
    Mayo Clin Health Lett; 2002 Jul; 20(7):4. PubMed ID: 12132472
    [No Abstract]   [Full Text] [Related]  

  • 2. Kava: a supplement to avoid.
    Consum Rep; 2003 Mar; 68(3):8. PubMed ID: 12599340
    [No Abstract]   [Full Text] [Related]  

  • 3. Kava concerns. FDA, Botanical Council raises safety concerns.
    AWHONN Lifelines; 2002; 6(1):13-5. PubMed ID: 11971236
    [No Abstract]   [Full Text] [Related]  

  • 4. The curious case of Kava.
    Grossman L
    Time; 2002 Apr; 159(14):58. PubMed ID: 11951318
    [No Abstract]   [Full Text] [Related]  

  • 5. Kava consumption and its health effects.
    Gounder R
    Pac Health Dialog; 2006 Sep; 13(2):131-5. PubMed ID: 18181402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered mental status and ataxia secondary to acute Kava ingestion.
    Perez J; Holmes JF
    J Emerg Med; 2005 Jan; 28(1):49-51. PubMed ID: 15657005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The latest drugs on the FDA's radar.
    Waldron T
    Behav Healthc; 2006 Jun; 26(6):34-5. PubMed ID: 16833213
    [No Abstract]   [Full Text] [Related]  

  • 8. FDA'S food ingredient approval process: Safety assurance based on scientific assessment.
    Rulis AM; Levitt JA
    Regul Toxicol Pharmacol; 2009 Feb; 53(1):20-31. PubMed ID: 18983884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural-born killers.
    Mandavilli A
    Nat Med; 2003 Jun; 9(6):634-5. PubMed ID: 12778149
    [No Abstract]   [Full Text] [Related]  

  • 10. Another FDA warning: Kava supplements.
    Parkman CA
    Case Manager; 2002; 13(4):26-8. PubMed ID: 12131903
    [No Abstract]   [Full Text] [Related]  

  • 11. Microbiologist appointed to direct FDA's foods center.
    FDA Consum; 2004; 38(2):4. PubMed ID: 15101354
    [No Abstract]   [Full Text] [Related]  

  • 12. Risky pills: supplements to avoid.
    Consum Rep; 2008 Jan; 73(1):46-7. PubMed ID: 18488285
    [No Abstract]   [Full Text] [Related]  

  • 13. Dangerous supplements: still at large.
    Consum Rep; 2004 May; 69(5):12-7. PubMed ID: 15104077
    [No Abstract]   [Full Text] [Related]  

  • 14. The FDA's plan for action.
    Lipman AG
    Hosp Formul; 1985 Dec; 20(12):1211. PubMed ID: 10274574
    [No Abstract]   [Full Text] [Related]  

  • 15. Risk of kava hepatotoxicity and the FDA consumer advisory.
    Teschke R; Schulze J
    JAMA; 2010 Nov; 304(19):2174-5. PubMed ID: 21081732
    [No Abstract]   [Full Text] [Related]  

  • 16. FDA's compendial--related activities.
    Konnor CA
    J Parenter Sci Technol; 1986; 40(1):30-3. PubMed ID: 3701540
    [No Abstract]   [Full Text] [Related]  

  • 17. Putting FDA's procedural house in order.
    Corwin E
    FDA Consum; 1975; 9(6):24-6. PubMed ID: 10308119
    [No Abstract]   [Full Text] [Related]  

  • 18. FDA's classification of new drugs.
    Schneiweiss F
    N Engl J Med; 1980 Jun; 302(24):1368-9. PubMed ID: 7374693
    [No Abstract]   [Full Text] [Related]  

  • 19. FDA's new bureau of veterinary medicine.
    Freeman A
    J Am Vet Med Assoc; 1966 Apr; 148(7):812-3. PubMed ID: 5959969
    [No Abstract]   [Full Text] [Related]  

  • 20. Status of FDA's Salmonella program.
    Hospitals; 1968 May; 42(10):113. PubMed ID: 5694970
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.